Key Developments: Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

149.11USD
4:04pm EDT
Price Change (% chg)

$-0.19 (-0.13%)
Prev Close
$149.30
Open
$149.24
Day's High
$150.19
Day's Low
$148.44
Volume
46,167
Avg. Vol
57,003
52-wk High
$221.00
52-wk Low
$143.14

Search Stocks

Latest Key Developments (Source: Significant Developments)

Core Laboratories NV gives Q3 2014 guidance in line with analysts' estimates; gives Q4 2014 guidance; revenue guidance below analysts' estimates
Wednesday, 23 Jul 2014 05:21pm EDT 

Core Laboratories NV:Expects Q3 2014 revenue of about $280 million to $290 million.Expects Q3 2014 EPS to range between $1.49 and $1.52.Expects Q4 2014 revenue of $285 million to $295 million with EPS ranging between $1.56 and $1.61.Q3 2014 revenue of $286 million and EPS of $1.52 - Thomson Reuters I/B/E/S.Q4 2014 revenue of $297 million and EPS of $1.61 - Thomson Reuters I/B/E/S.  Full Article

Core Laboratories NV announces Q3 2014 quarterly dividend
Tuesday, 8 Jul 2014 04:14pm EDT 

Core Laboratories NV:Declares cash dividend of $0.50 per share of common stock payable in the third quarter of 2014.On an annualized basis, this quarterly dividend would equal a total payout of $2.00 per share of common stock, if maintained for the entire year.Quarterly $0.50 per share cash dividend will be payable on Aug. 18, 2014 to shareholders of record on July 18, 2014.  Full Article

Core Laboratories NV lowers Q2 2014 guidance
Monday, 12 May 2014 02:00am EDT 

Core Laboratories NV:Sees Q2 2014 EPS guidance in the range of $1.32 - $1.35 range.Sees Q2 2014 revenue ranging from $265 mln to $270 mln.  Full Article

Core Laboratories NV gives Q2 2014 guidance - Conference Call
Thursday, 24 Apr 2014 12:30pm EDT 

Core Laboratories NV:Expects Q2 2014 revenue to range between $280-$286 mln.Expects Q2 2014 EPS guidance would range from $1.48-$1.53.  Full Article

Core Laboratories NV gives Q2 2014 EPS guidance; revenue guidance below analysts' estimates; lowers FY 2014 revenue guidance; reaffirms FY 2014 EPS guidance
Wednesday, 23 Apr 2014 05:32pm EDT 

Core Laboratories NV:Expects Q2 2014 revenue to range between $280,000,000 and $286,000,000.Expects Q2 2014 EPS guidance would range from $1.48 to $1.53.Expects FY 2014 revenue to range between about $1,155,000,000 and $1,175,000,000.Expects FY 2014 EPS ranging from about $6.00 to about $6.25.Q2 2014 revenue of $290 million and EPS of $1.53 - Thomson Reuters I/B/E/S.FY 2014 revenue of $1.178 billion and EPS of $6.23 - Thomson Reuters I/B/E/S.  Full Article

Core Laboratories NV announces Q2 2014 quarterly dividend
Monday, 14 Apr 2014 06:52pm EDT 

Core Laboratories NV:Announces cash dividend of $0.50 per share of common stock payable in second quarter of 2014.On annualized basis, this quarterly dividend would equal total payout of $2.00 per share of common stock, if maintained for entire year.Quarterly $0.50 per share cash dividend will be payable on May 23, to shareholders of record on April 25.  Full Article

Core Laboratories NV gives Q1 2014 guidance in line with analysts' estimates; gives FY 2014 EPS guidance; revenue guidance below analysts' estimates
Wednesday, 29 Jan 2014 05:19pm EST 

Core Laboratories NV:Expects Q1 2014 core revenue to range between $280 to $286 million.Expects Q1 2014 EPS guidance would range from $1.43 to $1.45.Expects FY 2014 core revenue to range between about $1.160 to $1.181 billion.Expects FY 2014 EPS ranging from about $6.00, applying 40pct full year-over-year incremental margins to the lower projected revenue level, to about $6.25.Q1 2014 revenue of $281 million and EPS of $1.43 - Thomson Reuters I/B/E/S.FY 2014 revenue of $1.192 billion and EPS of $6.17 - Thomson Reuters I/B/E/S.  Full Article

Core Laboratories NV announces Q1 2014 quarterly dividend
Monday, 13 Jan 2014 12:46pm EST 

Core Laboratories NV:Says a cash dividend of $0.50 per share of common stock payable in the first quarter of 2014.Says this amount represents a 56.25 pct increase over the quarterly dividends of $0.32 per share that were paid in 2013.Says on an annualized basis, this first quarterly dividend would equal a total payout of $2.00 per share of common stock, if maintained for the entire year.Says the quarterly $0.50 per share cash dividend will be payable on Feb. 21 to shareholders of record on Jan. 24.  Full Article

Core Laboratories NV Raises Q4 2013 Guidance
Wednesday, 16 Oct 2013 05:04pm EDT 

Core Laboratories NV announced that for the fourth quarter of 2013, it expects revenue to range between $278,000,000 and $281,000,000, with EPS in the $1.39 to $1.40 range. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $273 million and EPS of $1.38 for the fourth quarter of 2013.  Full Article

Core Laboratories NV Announces Quarterly Dividend
Tuesday, 8 Oct 2013 04:09pm EDT 

Core Laboratories NV announced a cash dividend of $0.32 per share of common stock payable in the fourth quarter of 2013. The quarterly $0.32 per share cash dividend will be payable on November 20, 2013 to shareholders of record on October 18, 2013.  Full Article

Search Stocks